Exchange: NYSE·Updated 07:30 PM EST

MED News

News
all
press releases
Medifast (NYSE:MED) Director Purchases 85,150 Shares of Stock
Medifast Inc (NYSE:MED - Get Free Report) Director Parsa Kiai bought 85,150 shares of the company's stock in a transaction dated Thursday, November 19th. The shares were acquired at an average price of $12.05 per share, for a total transaction of $1,026,057.50. Following the completion of the...
MarketBeat
Medifast (NYSE:MED) Director Purchases 85,150 Shares of Stock
Medifast Inc (NYSE:MED - Get Free Report) Director Parsa Kiai bought 85,150 shares of the company's stock in a transaction dated Thursday, November 19th. The shares were acquired at an average price of $12.05 per share, for a total transaction of $1,026,057.50. Following the completion of the...
MarketBeat
More News
Medifast Inc (NYSE:MED - Get Free Report) Director Parsa Kiai purchased 8,886 shares of the firm's stock in a transaction on Wednesday, November 18th. The shares were purchased at an average cost of $12.16 per share, for a total transaction of $108,053.76. Following the completion of the purchase...
MarketBeat
MED is positioning Trilivy as a complement to GLP-1 medications, combining nutrition and coaching to support sustainable metabolic health and weight management.
Zacks
MED advances its metabolic health strategy through a new Institute, proprietary science and Trilivy's phased wellness system.
Zacks
Key PointsAverage revenue per active coach rose 54% year over year...
Nasdaq News: Markets
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
(RTTNews) - Medifast, Inc. (MED), a metabolic health and wellness company, on Monday reported higher loss during the third quarter, impacted by restructuring charges and lower revenues. Further, the company issued fourth-quarter outlook expecting profit. For fiscal 2026, the comp...
Nasdaq News: Markets
Medifast (NYSE:MED) reported third-quarter financial results on Monday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...
Benzinga
Medifast (MED) delivered earnings and revenue surprises of +52.50% and +5.89%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy, today reported results for the third quarter ended September 30, 2026. Third Quarter 2026 Revenue: $72.0 million, with revenue per active earning coach of...
Business Wire

Advertisement|Remove ads.